Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors [1] (multiple letters)

Cancer

Volumn 103, Issue 8, 2005, Pages 1756-1757

  Tanvetyanon, Tawee ^a   Hines Jr , Edward ^b   Rosen, Lee S ^c  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b E Hines   (United States)

^c JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID; ZOLEDRONIC ACID;

AVASCULAR NECROSIS; BONE METASTASIS; BREAST CARCINOMA; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; HUMAN; HYPOCALCEMIA; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY DYSFUNCTION; LETTER; LONG TERM CARE; LUNG NON SMALL CELL CANCER; MORBIDITY; NEPHROTOXICITY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RISK ASSESSMENT; SOLID TUMOR;

EID: 16844362820     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20996     Document Type: Letter

References (0)